Your browser doesn't support javascript.
loading
1-Year Prospective Study of the Relationship of Serial Exhaled Nitric Oxide Level and Asthma Control.
Ko, Fanny Wai San; Chan, Ka Pang; Ng, Joyce Ka Ching; Ngai, Jenny C L; Yip, Wing Ho; Lo, Rachel Lai Ping; Chan, Tat On; Hui, David Shu Cheong.
Afiliação
  • Ko FWS; Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong, People's Republic of China.
  • Chan KP; Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong, People's Republic of China.
  • Ng JKC; Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong, People's Republic of China.
  • Ngai JCL; Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong, People's Republic of China.
  • Yip WH; Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong, People's Republic of China.
  • Lo RLP; Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong, People's Republic of China.
  • Chan TO; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.
  • Hui DSC; Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong, People's Republic of China.
J Asthma Allergy ; 16: 725-734, 2023.
Article em En | MEDLINE | ID: mdl-37469451
ABSTRACT
Background and

Objective:

Previous studies found that the fractional nitric oxide concentration in exhaled breath (FeNO) levels in healthy Chinese adults was higher than in White adults. More understanding of serial changes of FeNO levels with asthma control in a real-life clinical setting would be important to explore the utility of this biomarker in routine asthma management. This study assessed the FeNO levels of Chinese asthma subjects with different levels of asthma control and the serial changes with respect to the changes in asthma control over 1 year.

Methods:

A 12-month prospective study (subjects recruited between November 2019 and January 2021) with serial measurement of FeNO levels at baseline, 4, 8 and 12 months. Asthma control was assessed by the Global Initiative for Asthma classification, Asthma Control Test (ACT) and Asthma Control Questionnaire (ACQ).

Results:

Altogether, 136 subjects (mean age 51.51±15.09 years, 46[33.8%] male) had successful baseline FeNO measurements. At baseline, the FeNO levels did not show a statistically significant difference for controlled, partly controlled and uncontrolled asthma according to GINA classification, ACT and ACQ. FeNO levels decreased with improving asthma control and stayed at similar levels with unchanged or worsening asthma control for all subjects. For subjects with baseline blood eosinophil levels ≥300 cells/µL(n=59), FeNO levels decreased with improving asthma control, stayed similar without change for asthma control and increased with worsening asthma control. Receiver operating characteristic (ROC) analysis with the highest area under curve (AUC) for changes in FeNO levels for improving asthma control was between ≤ -10 to -25 ppb at various time points in the 12-month study.

Conclusion:

Changes in FeNO levels over time were associated with changes in clinical asthma control, particularly in those with higher blood eosinophil count and are likely more useful than a single time point measurement in managing asthma.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article